Pular para o conteúdo
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Idioma
Todos os campos
Título
Autor
Assunto
Número de Chamada
ISBN/ISSN
Tag
Buscar
Avançada
Preliminary phase IISOCRATES s...
Citar
Enviar por SMS
Enviar por e-mail
Imprimir
Exportar registro
Exportar para RefWorks
Exportar para EndNoteWeb
Exportar para EndNote
Link permanente
Preliminary phase IISOCRATES study results: Capecitabine (CAP) combined with oxaliplatin (OX) and preoperative radiation (IRT) in patients (pts) with locally advanced rectal cancer (LARC).
Detalhes bibliográficos
Principais autores:
Glynne-Jones, R
,
Sebag-Montefiore, D
,
McDonald, A
,
Falk, S
,
Maughan, T
Formato:
Conference item
Publicado em:
2004
Itens
Descrição
Registros relacionados
Registro fonte
Registros relacionados
Socrates phase II study results: Capecitabine (CAP) combined with oxaliplatin (OX) and preoperative radiation (RT) in patients (pts) with locally advanced rectal cancer (LARC).
por: Glynne-Jones, R, et al.
Publicado em: (2005)
A phase I/II study of oxaliplatin when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group (CCOG) study.
por: Sebag-Montefiore, D, et al.
Publicado em: (2005)
A phase I/II study of irinotecan when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group Study.
por: Glynne-Jones, R, et al.
Publicado em: (2007)
Capecitabine (X) and oxaliplatin (O) combination chemotherapy in patients (pts) with advanced gall bladder or biliary tract cancer: A phase II study
por: Evans, T, et al.
Publicado em: (2006)
Preoperative chemoradiotherapy with capecitabine and triweekly oxaliplatin versus capecitabine monotherapy for locally advanced rectal cancer: a propensity-score matched study
por: Anchuan Li, et al.
Publicado em: (2022-07-01)